These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16196371)

  • 21. Tumor Handling of Early-stage Cervical Cancer: A Literature Analysis of Villoglandular Adenocarcinoma of the Cervix.
    Dietl A; Aumann K; Beckmann MW
    Anticancer Res; 2020 Jun; 40(6):3049-3053. PubMed ID: 32487598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reevaluation for overlooked signs of cervical smears in cases of uterine cervical adenocarcinoma].
    Kutsuzawa T; Yamada Y; Ishizaki Y; Sato C; Kaneko M; Moriya S; Ichinoe K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2598-604. PubMed ID: 6520480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytological check-ups after treatment of premalignant conditions in the uterine cervix].
    Nøstdahl W
    Tidsskr Nor Laegeforen; 1993 Jun; 113(15):1884-5. PubMed ID: 8322336
    [No Abstract]   [Full Text] [Related]  

  • 24. Adenoma malignum of the uterine cervix--an enigma.
    Dasgupta S; Aich RK; Deb AR; Gupta P
    J Indian Med Assoc; 2012 Dec; 110(12):929-30. PubMed ID: 23936961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix: a case report.
    Lu FH; Chen BF; Yang YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):436-40. PubMed ID: 9699398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytologic features of well-differentiated villoglandular adenocarcinoma of the cervix.
    Ballo MS; Silverberg SG; Sidawy MK
    Acta Cytol; 1996; 40(3):536-40. PubMed ID: 8669191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary relapse of acute lymphoblastic leukemia in a cervical smear: a case report.
    Ikuta A; Saito J; Mizokami T; Asano M; Nakamoto T; Nakajima T; Matsunami M; Yasuda K; Adachi Y; Kanzaki H
    Diagn Cytopathol; 2006 Jul; 34(7):499-502. PubMed ID: 16783771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adenocarcinoma of the endocervix. Clinical cases].
    Zarcone R; Tartaglia E; Cardone G; Voto RI
    Minerva Ginecol; 1994; 46(1-2):45-8. PubMed ID: 8177462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytologic features of endocervical glandular lesions: comparison of SurePath, ThinPrep, and conventional smear specimen preparations.
    Belsley NA; Tambouret RH; Misdraji J; Muzikansky A; Russell DK; Wilbur DC
    Diagn Cytopathol; 2008 Apr; 36(4):232-7. PubMed ID: 18335553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive adenocarcinoma and related tumors of the uterine cervix.
    Young RH; Scully RE
    Semin Diagn Pathol; 1990 Aug; 7(3):205-27. PubMed ID: 2218147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix.
    Datta CK
    W V Med J; 1997; 93(4):186-8. PubMed ID: 9274143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytologic features of villoglandular adenocarcinoma of the uterine cervix: comparison with typical endocervical adenocarcinoma with a villoglandular component and papillary serous carcinoma.
    Chang WC; Matisic JP; Zhou C; Thomson T; Clement PB; Hayes MM
    Cancer; 1999 Feb; 87(1):5-11. PubMed ID: 10096353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis.
    Ceballos KM; Shaw D; Daya D
    Am J Surg Pathol; 2006 Mar; 30(3):370-4. PubMed ID: 16538058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological features of well-differentiated cervical adenocarcinoma with abundant mucus secretion.
    Ueki M; Ueda M; Okamura S; Yamada T
    J Med; 1995; 26(1-2):17-30. PubMed ID: 7561528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal deviation adenocarcinoma of the uterine cervix.
    Chen YP; Ho SP; Liou WS; Chen CJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):447-9. PubMed ID: 26384069
    [No Abstract]   [Full Text] [Related]  

  • 36. Arias-Stella reaction in a cervicovaginal smear of a woman undergoing infertility treatment: a case report.
    Lui M; Boerner S
    Diagn Cytopathol; 2005 Feb; 32(2):94-6. PubMed ID: 15637674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the ovarian preservation safe in young women with stages IB-IIA villoglandular adenocarcinoma of the uterine cervix?
    Ju UC; Kang WD; Kim SM
    J Gynecol Oncol; 2018 Jul; 29(4):e54. PubMed ID: 29770624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ.
    Miller B; Dunn J; Dalrymple J; Krivak TC
    Gynecol Oncol; 2005 Nov; 99(2):489-92. PubMed ID: 16054200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.
    Dietl AK; Beckmann MW; Aumann K
    Arch Gynecol Obstet; 2021 Aug; 304(2):317-327. PubMed ID: 34036437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lethal endometrial recurrence after cone biopsy for microinvasive cervical adenocarcinoma.
    Singh P; Scurry J; Proietto A
    J Obstet Gynaecol Res; 2008 Jun; 34(3):413-7. PubMed ID: 18588617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.